TRIANGULAR SHAPES DESIGN

View On IC.GC.CA

REGISTERED

on 21 Sept 2022

Last Applicant/ Owned by

INCYTE HOLDINGS CORPORATION

1801 Augustine Cut-OffWilmington DE 19803

Serial Number

2008875 filed on 29^th Nov 2019

Registration Number

TMA1142578 registered on 21^st Sept 2022

Registration expiry Date

29^th Nov 2029

Correspondent Address

LAVERY, DE BILLY, LLP

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

H3B4M4

TRIANGULAR SHAPES DESIGN

Trademark usage description

pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer, restenosis and metabolic diso Read More

Vienna Information

18 . 5 . 1

Aeroplanes, helicopters -- Notes: (a) Including parts of aeroplanes (tails, wings, cockpits, etc.). -- (b) Not including propellers for aircraft (15.1.13).Avions, hélicoptères -- Notes: (a) Y compris les parties d'avions (queues, ailes, cockpits, etc.). -- (b) Non compris les hélices d'avions (15.1.13).

18 . 5 . 3

Stylized aeroplanesAvions stylisés

20 . 5 . 25

Paper in rolls, wallpaper, other papers and documents -- Note: Including toilet paper and paper towels.Papiers en rouleaux, papiers peints, autres papiers et documents -- Note: Y compris le papier hygiénique et les essuie-mains en papier.

26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

Classification Information

Class [005]
Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer, restenosis and metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, chronic obstructive pulmonary disease, inflammatory diseases of the thyroid, pelvic inflammatory disease, arthritis, asthma; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents for medical use, namely clinical diagnostic reagents; biological preparations for medical and veterinary purposes for use in the treatment metabolic disorders, cancer, inflammatory diseases of the thyroid, pelvic inflammatory diseases, and restenosis.

Classification kind code

Class [042]
Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research and medical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; providing medical and scientific research information in the field of pharmaceuticals; research and development services in the field of antibodies.

Classification kind code

Mark Details

Serial Number

2008875

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 25^th Oct 2021	Agent Changed
Submitted for opposition 22 on 20^th May 2021	Search Recorded
Submitted for opposition 20 on 20^th May 2021	Examiner's First Report
Submitted for opposition 223 on 20^th May 2021	Total Provisional Refusal
Submitted for opposition 256 on 30^th Nov 2020	Notification of Possible Opposition Sent
Submitted for opposition 257 on 30^th Jan 2020	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 29^th Jan 2020	Formalized
Submitted for opposition 1 on 29^th Jan 2020	Created
Submitted for opposition 228 on 29^th Nov 2019	International Registration
Submitted for opposition 30 on 29^th Nov 2019	Filed